Market revenue in 2023 | USD 7.2 million |
Market revenue in 2030 | USD 12.9 million |
Growth rate | 8.6% (CAGR from 2023 to 2030) |
Largest segment | Human donor tissue-derived products |
Fastest growing segment | Human Donor Tissue-Derived Products |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Human Donor Tissue-Derived Products, Acellular Animal-derived Products |
Key market players worldwide | 3M Co, Organogenesis Holdings Inc Class A, Integra Lifesciences Holdings Corp, Smith & Nephew PLC, MiMedx Group Inc, Essity AB Class B, Stryker Corp, Vericel Corp, Mallinckrodt PLC Ordinary Shares - New, Tissue Regenix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biological skin substitutes market will help companies and investors design strategic landscapes.
Human donor tissue-derived products was the largest segment with a revenue share of 66.67% in 2023. Horizon Databook has segmented the Australia biological skin substitutes market based on human donor tissue-derived products, acellular animal-derived products covering the revenue growth of each sub-segment from 2018 to 2030.
There is a high demand for a wide range of medical equipment in Australia. The market is very competitive and mature. The country's population expects superior-quality medical treatments, and there is a constant need for state-of-the-art medical products.
The demand for medical products and other healthcare services is projected to increase, owing to continuous technological developments, rapidly aging population, increasing burden of chronic diseases, and growing individual income.
Australia has one of the longest life expectancies across the globe & the demand for medical devices is expected to grow with increase in the geriatric population. Opportunities exist for products that can provide a significant improvement in clinical outcomes.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia biological skin substitutes market , including forecasts for subscribers. This country databook contains high-level insights into Australia biological skin substitutes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account